These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Oncoimmunology: some fundamental problems of cancer immunotherapy]. Nedospasov SA, Kuprash DV. Mol Biol (Mosk); 2007; 41(2):355-68. PubMed ID: 17514902 [Abstract] [Full Text] [Related]
8. Immunotherapeutics in development for prostate cancer. Harzstark AL, Small EJ. Oncologist; 2009 Apr; 14(4):391-8. PubMed ID: 19342474 [Abstract] [Full Text] [Related]
9. The potential beneficial effects of drugs on the immune response to vaccination. Liu WM, Dalgleish AG. Semin Oncol; 2012 Jun; 39(3):340-7. PubMed ID: 22595056 [Abstract] [Full Text] [Related]
14. [Effect of chemotherapy on anticancer immune effector cells]. Saijo N. Gan To Kagaku Ryoho; 1983 Mar; 10(3):699-707. PubMed ID: 6410999 [Abstract] [Full Text] [Related]
15. Cancer vaccines for established cancer: how to make them better? Andrews DM, Maraskovsky E, Smyth MJ. Immunol Rev; 2008 Apr; 222():242-55. PubMed ID: 18364006 [Abstract] [Full Text] [Related]
20. A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting. Gray A, Raff AB, Chiriva-Internati M, Chen SY, Kast WM. Immunol Rev; 2008 Apr 15; 222():316-27. PubMed ID: 18364011 [Abstract] [Full Text] [Related] Page: [Next] [New Search]